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ABSTRACT
Background: Antiretroviral drugs were introduced to help reduce HIV mortality rate by increasing the
immunity of the infected persons, to reduce the viral load of the virus and to take advantage of its additional
benefits such as its effectiveness against bacteremia and urinary tract infections (UTIs). The purpose of the
study is to investigate the prevalence rate of asymptomatic UTIs among ART users and non-users, and to
identify the causative agents and their susceptibility to commonly used antimicrobial agents.
Methods: A cross-sectional study was conducted between January and April 2018 at the Cape Coast Teaching
Hospital. A single ‘clean catch’ urine was obtained from 240 HIV patients and immediately sent to the
laboratory for culture. The isolates were considered significant if there were ≥105 colony forming unit/mL
(CFU/mL). Significant isolates were identified by methods, such as Gram staining and biochemical tests.
Various descriptive and inferential statistics were carried out using SPSS version 21 and the P-values <0.05
were considered significant.
Results: Out of 240 patients recruited for this study, 177(73.8%) of them had significant bacteriuria, while
Staphylococcus aureus (39%) was the predominant bacterial isolate. There were significant associations
between UTIs and age, sex, marital status, and educational level. All bacterial isolates were found among
females and mostly among ART users.
Conclusion: Most the recruited patients had asymptomatic urinary tract infections of which many were
females and ART users. Considering this, regular screening should be done on HIV patients.
Keywords: Antiretroviral drugs; Urinary tract infections; Prevalence; Antimicrobial agents; HIV-
infected patients
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INTRODUCTION
About 36.7 million people were living with
HIV/AIDS worldwide in 2016 out of which 1 million
died from AIDS-related illnesses of which urinary
tract infections (UTIs) are not an exception. Most of
these individuals are said to be in low- and middle-
income countries (UNAID, 2016). People living with
Human Immunodeficiency Virus (HIV) are mostly at
risk of getting urinary tract infection due to the
suppression of their immunity indicated by the
decreased levels of the CD4 count. Research has
shown that UTIs become more persistent when CD4
count further reduces (Bigwan & Wakjissa,
2013).Current literature has revealed a significant
number of bacteria causing UTIs in HIV-infected
patients; Staphylococcus aureus, Escherichia coli,
Proteus spp., Enterobacter spp., Klebsiella spp.,
Pseudomonas aeruginosa, Streptococcus faecalis, and
Staphylococcus saprophyticus with the unusual
microbes being Serratia spp., Candida spp.,
Salmonella spp., Providentia spp., Acinetobacter spp.,
Citrobacter spp., and Cytomegalovirus (Schonwald,
Begovac and Skerk., 1999; Bigwan and Wakjissa,
2013; ) Asymptomatic urinary tract infection is
defined by the quantity of cultured bacteria isolated
from an appropriately collected urine specimen,
exceeding 105 cfu/ml, obtained from an individual
showing no symptoms or signs of the infection
(Cheeseborough, 2000). Global prevalence rate of
UTIs is between 5% and 41%. A higher rate of
prevalence rate for UTIs in HIV-infected persons
have been reported from Ghana (86%), and Nigeria
(94%) (Ifeanyichukwu, et al., 2013; Boaitey,
Nkrumah, Idriss & Tay 2012).
Studies have indicated the additional benefits of
antiretroviral drugs, such as the reduction in urinary
tract infections, bacteremia and bacterial pneumonia
(Donati, 2003). However, other studies have revealed
contradictory data reporting that the UTI causing
bacteria are more prevalent among ART users
(Debalke, Cheneke, Tassew & Awol, 2014; Fenta,
Legese & Weldearegay, 2016; Alemu, Dagnew,
Alem, & Gizachew, 2013). So could this mean
therefore that the ART’s do not protect HIV patients
against UTI causing bacteria? Bacterial resistance to
some commonly used antimicrobial agents has been
on the rise and this development has been implicated
in the failure of these agents for treating infectious
diseases including UTIs (Muratani & Matsumoto,
2004). As far as our literature to date is concerned,
there is limited information on the prevalence,
causative agents, and the antimicrobial susceptibility
pattern of bacterial pathogens among HIV-infected
patients in Ghana. Thus, the current study was aimed
at determining the prevalence of Asymptomatic UTIs,
the causative agent and antimicrobial susceptibility
pattern of urinary tract pathogens among ART users
and non-users in Cape Coast Teaching Hospital.
MATERIALS ANDMETHODS
Study Area, Design and Population
A prospective and comparative cross-sectional study
was conducted between January and June 2018 in the
Cape Coast Teaching Hospital (CCTH), Cape Coast,
in the Central Region of Ghana. In the study, 240
HIV infected patients attending the ART clinic were
recruited based on convenient sampling technique
and their respective urine samples were collected and
immediately transported to the bacteriology section
of the Department of Biomedical Science Laboratory
for culturing. HIV infected patients who were ART
users and non-users and gave consent were included
in the study. Whereas, HIV infected patients with
symptomatic UTIs, those below 15 years, pregnant
mothers, and those who were on antimicrobial
therapy for two years prior to data collection and
those who did not give consent were excluded from
the study.
Sample Collection and Processing
A structured, pretested questionnaire was used to
collect data on sociodemographic characteristics and
other independent variables whiles the CD4 counts of
the participants were retrieved from their hospital
folders. Clean-catch midstream urine was obtained
from participants using a sterile wide mouth urine
container. The participants were educated on the
appropriate urine collection methods. The containers
were labelled with the sample identity (ID), time of
collection and transported to the laboratory within
one hour of collection for culture and antibiotic
susceptibility testing.
Culture and antimicrobial susceptibility
pattern
A sterile calibrated inoculating loop that delivers
0.01ml is immersed just below the surface of the
urine to pick up urine samples. This loop with the
urine was streaked on the plates containing Blood
agar and MacConkey agar (Oxoid, England) without
touching the edge of the plate. After inoculation, the
plates were incubated at 37 ℃ for 24 hours for
bacterial growth. The colonies on each plate were
counted (isolates ≥ 105 colony forming units were
considered significant). Bacterial isolates were
identified based on colony morphology, Gram
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reaction and biochemical tests, such as triple sugar
iron (TSI), catalase, coagulase, mannitol
fermentation, urease, indole and citrate following
standard operating procedures.
Antimicrobial sensitivity test was done to determine
the susceptibility patterns of the isolated bacteria to
some selected antibiotics (12 for both Gram positive
and Gram negative) using Kirby Bauer’s disk
diffusion method following Clinical and Laboratory
Standard Institute (CLSI) guidelines. A standard
inoculum adjusted to 0.5 McFarland was swabbed
onto Muller-Hinton agar (Oxoid, England); antibiotic
discs were dispensed after drying the plates for 3-5
minutes and incubated at 37℃ for 16-18 hours. After
incubation, the zones of growth inhibition
were determined and then reported as sensitive(S)
and resistant (R) by comparing
the zones of inhibition with the standard table. The
antibiotic disks used were Ampicillin/Sulbactam
(AS,20µg), Co- Trimoxazole (BA, 25µg),
Cephalexin (PR,30µg), Tetracycline (TE, 30µg),
Cefotaxime (CF,30µg), Ciprofloxacin (CP, 5µg),
Prulifloxacin (PF, 5µg), Ofloxacin (OF,5µg),
Cloxacillin (CX, 5µg), Roxithromycin (RF, 15µg),
Linomycin (LM, 2µg), Gentamicin (GM,10µg),
Tazobactam/piperacillin (TZP, 100/10µg),
Chloramphenicol (CH, 30µg), Ceftizoxime (CI,
30µg), Amikacin (AK, 30µg), and Levofloxacin
(LEV, 5µg).
Quality Control
Culture media used in the study were tested for
sterility and quality following the Standard Operating
Procedures. Standard strains of Escherichia coli
ATCC 25922 and Staphylococcus aureus ATCC
25923 were used during culture and antimicrobial
susceptibility testing.
DATA ANALYSIS AND INTERPRETATION
Descriptive analyses (frequency and percentage)
were performed on sociodemographic using
statistical package for social science (SPSS) version
21 software. Chi-square analysis was done to
determine the presence of significant associations
between the dependent variables and independent
variables. P value of ˂ 0.05 was considered
statistically significant.
Ethical Considerations
Ethical approval for the study was obtained from the
Department of Biomedical Science, University of
Cape Coast and an official permission was also
obtained from the ethics committee of the Cape
Coast Teaching Hospital. Informed consent of each
patient was obtained. All information from the
participants were held strictly confidential.
RESULTS
In this study, 240 HIV patients visiting the HIV
clinic were examined. Out of these, 222 (92.5%)
were ART users whereas 18 (7.5%) were ART naive
patients. From the 240 samples obtained, 9 (3.8%)
had no bacterial growth after culturing whiles 177
(73.8%) had significant bacterial growth of which
165 (68.8%) were ART users and 12 (5%) were not
(Table 1).
The sociodemographic characteristics of the HIV
patients as indicated in Table 2 shows that 177
(76.6%) of the participants were females, 117 (50.6%)
were above 44 years, 102 (44.2%) were married, 207
(89.6%) were Christians, 93 (40.3%) were illiterates
and 169 (69.3%) were into unskilled labour. There
was a strong association between UTI and some
characteristics such as age (P=0.001), sex (P=0.016),
marital status (P=0.04) and educational level
(P<0.001) while there were no significant
associations between UTI and factors such as
religion, occupation, CD4 count and antiretroviral
(ART) use. The correlation between therapy length
and colony count and immune status and colony
count is shown in Table 3. There is a weak
correlation (r= 0.28) between length of therapy and
colony count. Similarly, there was a weak correlation
(r= -0.16) between CD4 count and colony count (P=
0.007).
We isolated eight different types of bacteria from the
urine culture of which Staphylococcus aureus (39.0%)
was the predominant amongst them followed by
Staphylococcus saprophyticus (23.7%), Citrobacter
spp (10.2%), Escherichia coli (8.5%), Proteus spp
(6.8%), Serratia sp (5.1%), Providentia sp (3.4%) and
Streptococcus (3.4%) (Figure 1). With Figure 2
illustrating the distribution of uropathogens by
gender, S. aureus being the most predominant was
found to be mostly associated with females (44.2%)
as compared to males (25.0% whiles S.
saprophyticus was common among males (31.3%)
than females (20.9%). Even though this study had
more females recruited, most of the bacteria
identified were associated with the males, most of
them being Gram-negative bacteria. Streptococcus
was only found in females and Citrobacter also
predominant in females. Comparing uropathogens
among ART users and non-users, Citrobacter (25%),
S. aureus (25%) and S. saprophyticus (50%) were the
only bacteria common among Non-ART users whiles
the rest were mostly associated with ART users
(Figure 3).
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Tables 6 and 7 shows the susceptibility patterns of
Gram-positive and Gram-negative bacteria isolated
form the urine cultures of ART and non-ART users.
Most (58%) of the Gram-positive isolated from ART
users were resistant to the antimicrobial used; co-
Trimoxazole (94.4%), tetracycline (94.4%),
cefotaxime (94.4%), linomycin (88.9%), cephalexin
(91.9%), roxithromycin (69.4%) and cloxacillin
(100%) while the rest (42%) were sensitive to
ampicillin (94.4%), gentamicin (86.1%),
ciprofloxacin (86.1%), prulifloxacin (58.3%) and
ofloxacin (77.8%). Likewise, 83% of the gram-
positive bacteria isolated from non-ART users were
resistant to ampicillin (100%), co-Trimoxazole
(66.7%), tetracycline (66.7%), cefotaxime (100%),
linomycin (100%), cephalexin (66.7%), prulifloxacin
(66.7%), roxithromycin (100%), ofloxacin (66.7%)
and cloxacillin (100%) with the rest being sensitive
to gentamicin (66.7%) and ciprofloxacin (66.7%).
For the Gram-negative bacteria, most were resistant
to ampicillin (52.6%), co-Trimoxazole (84.2%),
tetracycline (94.7%), cefotaxime (73.7%),
ciprofloxacin (52.6%), ofloxacin (63.2%),
chloramphenicol (94.7%) and ceftizoxime (85%)
while the rest were sensitive to gentamicin (68.4%),
tazobactam/piperacillin (94.7%), amikacin (68.4%)
and levofloxacin (89.5%). Citrobacter isolated from
non-ART users was 100% resistant to tetracycline
and ceftizoxime while sensitive to ampicillin, co-
Trimoxazole, gentamicin, cefotaxime, ciprofloxacin,
ofloxacin, tazobactam, chloramphenicol, amikacin
and levofloxacin.
Table 1: Prevalence of urinary tract infection among ART and non-
ART users in University of Cape Coast Teaching Hospital (CCTH).
Table 2: Prevalence of Asymptomatic UTI by sociodemographic
characteristics among HIV patients, CCTH.
Table 3. Influence of length of therapy and immune status (CD4
count) on colony count
Figure 1: Prevalence of isolated organisms among HIV patients in
Cape Coast Teaching Hospital
Figure 2: Distribution of etiological agents of UTI among gender at
Cape Coast Teaching Hospital.
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Figure 3: Distribution of etiologic agent of UTI among ART users
and Non-ART users in Cape coast University Teaching Hospital.
DISCUSSION
This study shows the occurrence and distribution of
asymptomatic urinary tract infection (UTI) among
ART users and non-users, and the antibiotic
susceptibility patterns of bacteria isolated from the
urine cultures of HIV-positive persons visiting the
HIV clinic of the Cape Coast Teaching Hospital.
From our study, the prevalence rate of asymptomatic
UTI among HIV/AIDS patients was 177/240 (73.8%)
as shown in Table 1. This prevalence rate is higher
than the prevalence rate reported in other studies
(Debalke, Cheneke, Tassew & Awol, 2014; Bigwan
and Wakjissa, 2013; Getu, Ali, Lema, Belay &
Yeshetela, 2017; Fenta, Legese & Weldearegay,
2016; Dielubanza & Schaeffer, 2011; Inyang-Etoh,
Udofia, Alaribe & Udonwa, 2009). The high
prevalence rate could be due to the immune status of
most of the participants in the study (36.4%) as
shown in Table 2 even though no significance
difference was recorded (P=0.180). A previous study
reported of the increased risk of UTI with reduction
in CD4 count (Bigwan and Wakjissa, 2013) which is
in agreement with the results shown in Table 3; the
weak correlation (r= -0.16) between CD4 count and
the colony count (P= 0.007) where R2 (0.03)
indicates that 0.03% of the variation in UTI as
represented by colony count is explained by immune
status (CD4 count). However, a study conducted in
Ghana and Nigeria revealed that 86% (60/70) and
94% (75/80) respectively, of the HIV seropositive
patients had asymptomatic UTI (Boaitey, Nkrumah,
Idriss & Tay 2012; Ifeanyichukwu, et al., 2013)
which is much higher than the prevalence rate found
in our study. This could be accounted for by the
higher number of HIV positive patients with < 200
cells per mm3 CD4 count which were not indicated in
their study. The study also found the prevalence of
no significance growth (<105 colony forming units
(cfu/ml)) and no growth to be 22.5% (54/240) and
3.8% (9/240) respectively. The percentage of no
growth on culture plates could be associated to
possible prior use of antibiotics before sampling
(Frank-Peterside, Okerentugba, Nwodo & Okonko,
2013) or the patients could be suffering from acute
urethral syndrome which is used to describe acute
cystitis accompanied by pyuria and no detection of
bacteria after urine culture (Cheeseborough, 2000).
There was a weak correlation (r= 0.28) between
length of ART therapy and colony count (P<0.001)
with R2 (0.08) indicating that how long a person
stays on ART therapy has a 0.08% influence on
increasing colony counts. Meanwhile, there was no
statistically significant (P= 1.00) association between
ART use (68.8%) or not (5%) and asymptomatic UTI.
The insignificance could be associated with the
smaller sample size of the non-ART user. Similarly,
other studies have shown a higher prevalence of UTI
in ART users as compared to non-ART users even
though some were significant (Debalke, Cheneke,
Tassew & Awol, 2014; Inyang-Etoh, Udofia, Alaribe
& Udonwa, 2009). In contrast, another study
conducted in Italy revealed that there was a reduction
in UTI among ART users (de Gaetano et al., 2003).
The prevalence of UTI among female patients
(55.8%) were significantly higher than male patients
(20.8%) as shown in Table 2 (P= 0.016) like other
studies (Getu, Ali, Lema, Belay & Yeshetela, 2017;
Fenta, Legese & Weldearegay, 2016; Dielubanza &
Schaeffer, 2011). This is because of the anatomy of
the female genitourinary tract. The female genital
tract enables the easy passage of uropathogens to the
bladder, and the urethra has proximity to the anal
region thereby facilitating the colonisation of the
microbes. However, considering the bacterial isolates
distribution among the female and male patients,
most of the bacterial isolates, S. saprophyticus
(31.3%), Proteus sp. (12.5%), E. coli (12.5%),
Providentia (6.3%) and Serratia (6.3%), were more
prevalent in male patients as compared to female
patients with only Staphylococcus aureus (44.2%),
Citrobacter (11.6%) and Streptococcus (4.7%) being
more prevalent. Infections caused by S.
saprophyticus are mostly associated with sexually
active young males (Cheeseborough, 2000).
The distribution of the bacterial isolates associated
with UTI among the HIV positive patients showed
Staphylococcus aureus (39%) to be the most
prevalent among the causative agents, followed by S.
saprophyticus (23.7%), Citrobacter (10.2%) and
Escherichia coli (8.5%). Proteus and S. aureus are
mostly associated with hospital acquired infections
(Cheeseborough, 2000). Our study showing
Staphylococcus aureus to be most common
uropathogen is supported by other studies
(Ifeanyichukwu, et al., 2013; Frank-Peterside,
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Okerentugba, Nwodo & Okonko, 2013; Omoregie
and Eghafona, 2009). In contrast, other studies have
identified Escherichia coli as the most prevalent
(Getu, Ali, Lema, Belay & Yeshetela, 2017; Alemu,
Dagnew, Alem, & Gizachew, 2013; Akinbami,
Bode-Shojobi, Ajibola, Oshinaike, & Adediran,
2013). Considering the distribution among ART
users and non-ART users, all 8 species of bacterial
isolates were associated with ART users while only
three were associated with the non-ART users. This
finding is similar to a study in Benin where there was
a significantly higher prevalence of asymptomatic
UTI among HAART users as compared to non-users
(Omoregie and Eghafona, 2009). In contrast to other
studies conducted in Ethiopia (Fenta, Legese &
Weldearegay, 2016; Debalke, Cheneke, Tassew &
Awol, 2014), Gram-positive isolates (66.1%) were
more prevalent than Gram-negative isolates
(33.9%).The Gram-positive bacteria isolated from
both ART users and non-users were susceptible to
only Gentamicin and Ciprofloxacin whiles being
resistant to Co-Trimoxazole, Tetracycline,
Cefotaxime, Linomycin, Cephalexin and Cloxacillin.
Variably, bacteria isolated from ART users were also
susceptible to Ampicillin (94.4%), Prulifloxacin
(58.3%) and Ofloxacin (77.8%), whiles those
isolated from the non-users were resistant. The
Gram-negative bacteria isolated from both ART
users and non-users were susceptible to Gentamicin,
Tazobactam, Amikacin, and Levofloxacin whiles
being resistant to Tetracycline and Ceftizoxime. This
finding is similar to other studies conducted in
Ethiopia where the Gram-negative bacteria were
resistant to Tetraycline, Ampicillin and
Sulfamethoxazole-Trimethoprim (Getu, Ali, Lema,
Belay & Yeshetela, 2017; Alemu, Dagnew, Alem, &
Gizachew, 2013). Variably, bacteria isolated from
ART users were resistant to Ampicillin (52.6%), Co-
Trimoxazole (84.2%), Cefotaxime (73.7%),
Ciprofloxacin (52.6%), Ofloxacin (63.2%) and
Chloramphenicol (94.7%). The varying degrees of
susceptibility and resistance to antimicrobial agents
is mostly due to the easy access to over-the-counter
drugs and the excessive use the drugs for animal
rearing and other animal husbandry activities;
thereby imposing some selective pressure on the
bacteria to develop resistance (Ifeanyichukwu, et al.,
2013). Generally, Gentamicin is the only
antimicrobial agent which is effective to both Gram-
positive and Gram-negative bacterial isolates while
Tetracycline is the least effective. Gentamicin seems
to be the most effective because of its route of
administration which makes it undesirable for people
to abuse.
CONCLUSION
In conclusion, our study found the prevalence of
asymptomatic UTI to be 73.8% which is above the
mostly reported range of 5%-41% worldwide. The
most prevalent isolated uropathogens are
Staphylococcus aureus, followed by Staphylococcus
saprophyticus, Citrobacter, Escherichia coli, Proteus,
Serratia, Providentia and Streptococcus sp. Bacteria
isolated from ART users were more as compared to
ART non-users. Moreover, with the varying degrees
of antibiotic susceptibility, gentamicin was found to
be effective against all the organism tested
irrespective of the ART status. It is therefore
recommended that urinary tract infections in both
ART users and non-users should be managed with
gentamicin until results from urine culture reveals the
predominant uropathogens and its susceptibility to
commonly used antibiotics. Regular screening for
UTIs and monitoring of ART adherence should be
conducted for HIV patients visiting the clinics. Also,
further studies should be conducted to investigate the
risk factors associated with the increased prevalence
of urinary tract infections.
REFERENCES
(1) Akinbami, A., Bode-Shojobi, I., Ajibola, S.,
Oshinaike, O., Adediran, A., & Ojelabi, O.
(2013). Prevalence of Asymptomatic Bacteriuria
in HIV Infected Patients in a Tertiary Hospital
in Lagos, Nigeria. World Journal of AIDS, 3,
105-110.
(2) Alemu, A., Dagnew, M., Alem, M., Gizachew,
M. (2013). Uropathogenic Bacterial Isolates and
their Antimicrobial Susceptibility Patterns
among HIV/AIDS Patients Attending Gondar
University Specialized Hospital Gondar,
Northwest Ethiopia. Journal of Microbiology
Research and Reviews. 1(4):42-51.
(3) Bigwan, E. I. and Wakjissa, F. D. (2013).
Prevalence of Urinary Tract Infections among
HIV Patients Attending a Non- Governmental
Health Facility in Jos, Plateau State, Nigeria.
International Journal of Biomedical And
Advance Research 4(8): 528- 533
(4) Boaitey, Y. A., Nkrumah, B., Idriss, A., & Tay,
S. C. K. (2012). Gastrointestinal and urinary
tract pathogenic infections among HIV
seropositive patients at the Komfo Anokye
Teaching Hospital in Ghana. BMC research
notes, 5(1), 454.
(5) Cheesbrough M. (2000). Examination of urine
and antimicrobial sensitivity testing. In: District
Laboratory Practice in Tropical Countries. Part
2 c Monica Cheesbrough, UK, Cambridge
University Press.
Volume 8 | Issue 1 | January-December -2019 [(8)1: 543-549] | http://onlinejournal.org.uk/index.php/ajmur
(6) Clinical and Laboratory Standards Institute
(CLSI) (2014). Performance Standards for
Antimicrobial Disk Susceptibility Tests;
Twenty-Second Informational Supplement.
CLIS 34: M100-S24
(7) Debalke, S., Cheneke, W., Tassew, H. & Awol,
M. (2014). Urinary Tract Infection among
Antiretroviral Users and Nonusers in Jimma
University Specialized Hospital, Jimma,
Ethiopia. Int J Microbio, 2014: 1-6.
(8) Dielubanza, E.J. & Schaeffer, A.J. (2011)
Urinary tract infections in women. Med Clin
North Am, 95 (1):27-41.
(9) Donati, K. D., Tumbarello, M., Tacconelli, E.,
Bertagnolio, S., Rabagliati, R., Scoppettuolo, G.
I., Citton, R. I., Cataldo, M., Rastrelli, E., Fadda,
G. I. & Cauda, R. (2003). Impact of highly
active antiretroviral therapy (HAART) on the
incidence of bacterial infections in HIV-infected
subjects. Journal of chemotherapy. 15(1):60-65.
(10) Fenta, G. M., Legese, M. H. & Weldearegay, G.
M (2016) Bacteriuria and their Antibiotic
Susceptibility Patterns among People Living
with HIV Attending Tikur Anbessa Specialized
and Zewditu Memorial Hospital ART Clinics,
Addis Ababa, Ethiopia. J Bacteriol Parasitol 7:
292.
(11) Frank-Peterside, N., Okerentugba, P. O., Nwodo,
C. R. & Okonko, I. O. (2013). Prevalence of
Bacterial Uropathogens in a cohort of HIV-
Positive Males in Port Harcourt, Nigeria. Cancer
Biology, 3(4):12-17.
(12) Getu, Y., Ali, I., Lema, T., Belay, H. &
Yeshetela, B. (2017). Bacteriuria and
Antimicrobial Susceptibility Pattern among HIV
Patients Attending ALERT Center, Addis Ababa,
Ethiopia. American Journal of Health Research,
5(3), 76-82.
(13) Ifeanyichukwu, I., Emmanuel, N., Chika, E.,
Anthonia, O., Esther, U., Ngozi, A. & Ngwu, J.
(2013). Frequency and Antibiogram of
uropathogens isolated from Urine Samples of
HIV Infected Patients on Antiretroviral Therapy.
American Journal of BioScience. 1(3):50-53.
(14) Inyang-Etoh, P. C., Udofa, G. C., Alaribe, A. A.
A. and Udonwa, N. E. (2009). Asymptomatic
bacteriuria in patients on antiretroviral drug
therapy in Calabar. Journal of Medical Sciences,
9(6), 270–275.
(15) Muratani, T. & Matsumoto, T. (2004). Bacterial
resistance to antimicrobials in urinary isolates.
Int journal of antimicrobial agents. 24: 28-31.
(16) Omoregie, R. & Eghafona, N.O. (2009). Urinary
tract infection among asymptomatic HIV
patients in Benin City, Nigeria. Br J Biomed Sci,
66(4): 190-193.
(17) Schonwald, S., Begovac, J. and Skerk, V. (1999).
Urinary Tract Infections in HIV disease. Int j
Antimicrob. Agents, 11, 309-311.
(18) UNAID. (2016). The Global HIV/AIDS
Epidemic. Retrieved from
https://www.hiv.gov/hiv-basics/overview/data-
and-trends/global-statistics.
